Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial
Title:
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial
Author:
Chen, Li-Tzong Siveke, Jens T. Wang-Gillam, Andrea Li, Chung-Pin Bodoky, György Dean, Andrew P. Shan, Yan-Shen Jameson, Gayle S. Macarulla, Teresa Lee, Kyung-Hun Cunningham, David Blanc, Jean-Frédéric Chiu, Chang-Fang Schwartsmann, Gilberto Braiteh, Fadi S. Mamlouk, Khalid Belanger, Bruce de Jong, Floris A. Hubner, Richard A.